Bleeding and recurrent thrombosis in definite antiphospholipid syndrome: Analysis of a series of 66 patients treated with oral anticoagulation to a target international normalized ratio of 3.5

Archives of Internal Medicine

Volumn 162, Issue 10, 2002, Pages 1164-1169

  Ruiz Irastorza, Guillermo ^a,b   Khamashta, Munther A ^a   Hunt, Beverley J ^a   Escudero, Alejandro ^a   Cuadrado, Maria J ^a   Hughes, Graham R V ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

^b HOSPITAL DE CRUCES   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; CARDIOLIPIN ANTIBODY; LUPUS ANTICOAGULANT; WARFARIN;

ADOLESCENT; ADULT; AGED; ANTICOAGULANT THERAPY; ANTIPHOSPHOLIPID SYNDROME; ARTERY THROMBOSIS; ARTICLE; BLEEDING; BRAIN HEMORRHAGE; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; HUMAN; INTERNATIONAL STANDARD UNIT; INTERVIEW; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RECTUM HEMORRHAGE; RECURRENT DISEASE; RETROPERITONEAL HEMORRHAGE; RETROSPECTIVE STUDY; STROKE; SUBDURAL HEMATOMA; THROMBOCYTOPENIA; THROMBOSIS; VEIN THROMBOSIS;

EID: 0037182043     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.162.10.1164     Document Type: Article

References (29)

1. Antiphospholipid thrombosis: Clinical course after the first thrombotic event in 70 patients
2. The management of thrombosis in the antiphospholipid-antibody syndrome
3. A retrospective review of 61 patients with antiphospholipid syndrome: Analysis of factors influencing recurrent thrombosis
4. Patients with antiphospholipid antibodies and venous thrombosis should receive long term anticoagulant treatment
5. Anticardiolipin antibodies predict early recurrence in thromboembolism and death among patients with venous thromboembolism following anticoagulant therapy
6. Antiphospholipid antibodies and venous thromboembolism
7. Guidelines on oral anticoagulation: Third edition
8. Guidelines on the investigation and management of the antiphospholipid syndrome
9. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome
10. Evaluation of the anticardiolipin antibody test: Report of a standardization workshop, held April 4th, 1986
11. Criteria for the diagnosis of lupus anticoagulants: An update
12. Audit of anticoagulant therapy
13. The 1982 revised criteria for the classification of systemic lupus erythematosus
14. Primary prevention of thrombosis in subjects with positive antiphospholipid antibodies
15. Clinical study of 100 patients with the antiphospholipid syndrome
16. Natural history and risk factors for thrombosis in 360 patients with antiphospholipid antibodies: A four-year prospective study from the Italian registry
17. Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: A meta-analysis
18. A randomized trial of anticoagulants versus aspirin after cerebral ischemia of presumed arterial origin
19. Prospective study to determine if trial efficacy of anticoagulation for stroke prevention in atrial fibrillation translates into clinical effectiveness
20. Bleeding complications of oral anticoagulant treatment: An inception-cohort, prospective collaborative study (ISCOAT)
21. A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism
22. Hemorrhagic complications of anticoagulant treatment
23. Bleeding during antithrombotic therapy in patients with atrial fibrillation
24. A multicomponent intervention to prevent major bleeding complications in older patients receiving warfarin: A randomized, controlled trial
25. Major bleeding during anticoagulation after cerebral ischemia: Patterns and risk factors
26. Prognostic factors and clustering of serious clinical outcomes in antiphospholipid syndrome
27. Characteristics of patients with antiphospholipid syndrome with major bleeding after oral anticoagulant treatment
28. Antiaggregant and anticoagulant therapy in systemic lupus erythematosus and Hughes' syndrome